Testing effectiveness (Phase 2)Study completedNCT01207687
What this trial is testing
Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)
Who this might be right for
Vestibular SchwannomaNeurofibromatosis Type 2
National Cancer Institute (NCI) 14